Counterfeit medicines and the threat they pose to patients have driven a global regulatory response of a wide-scale introduction of serialization or track-and-trace legislation in a bid to hinder these products’ entry into the supply chain. The shaping of a more secure, transparent, and connected supply chain that puts patients front of mind for…